| |
| |
|
| Insider
Information: |
Magnani John L. |
| Relationship: |
SVP of Research, CSO |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
366,078 |
|
|
Indirect Shares
|
4,845 |
|
|
| Direct
Value |
$97,596 |
|
|
|
Indirect Value
|
$1,292 |
|
|
| Total
Shares |
370,923 |
|
|
| Total
Value |
$98,888 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 29.0%
|
85.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Glycomimetics Inc |
GLYC |
SVP of Research, CSO |
2022-11-11 |
366,078 |
2022-11-11 |
4,845 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GLYC |
Glycomimetics Inc |
SVP of Research, CSO |
• – – |
2022-11-11 |
4 |
B |
$1.17 |
$52,703 |
D/D |
45,045 |
366,078 |
2.74 |
% |
|
| GLYC |
Glycomimetics Inc |
SVP of Research, CSO |
• – – |
2022-03-09 |
4 |
S |
$1.09 |
$3,517 |
D/D |
(3,227) |
321,033 |
0 |
% |
|
| GLYC |
Glycomimetics Inc |
SVP of Research, CSO |
• – – |
2021-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
34,500 |
324,260 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
SVP of Research, CSO |
• – – |
2020-01-06 |
4 |
OE |
$1.12 |
$119,821 |
D/D |
106,983 |
289,760 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
SVP of Research, CSO |
• – – |
2019-12-20 |
4 |
OE |
$1.12 |
$119,822 |
D/D |
106,984 |
182,777 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
SVP of Research, CSO |
• • – |
2018-10-18 |
4 |
AS |
$14.02 |
$49,449 |
D/D |
(3,527) |
75,793 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
SVP of Research, CSO |
• • – |
2018-10-17 |
4 |
AS |
$14.00 |
$101,822 |
D/D |
(7,273) |
79,320 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
SVP of Research, CSO |
• • – |
2018-10-16 |
4 |
AS |
$14.01 |
$198,942 |
D/D |
(14,200) |
86,593 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
SVP of Research, CSO |
• • – |
2018-05-23 |
4 |
OE |
$0.33 |
$492 |
D/D |
1,491 |
100,793 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
SVP of Research, CSO |
• • – |
2017-05-10 |
4 |
OE |
$1.12 |
$9,999 |
D/D |
8,928 |
99,302 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
VP of Research, CSO |
• • – |
2014-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,969 |
90,374 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
VP of Research, CSOOfficer |
• • – |
2014-01-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,845 |
|
- |
|
| GLYC |
Glycomimetics Inc |
VP of Research, CSOOfficer |
• • – |
2014-01-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
80,405 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
